
Discovery of potent, efficacious, and orally bioavailable inhibitors of blood coagulation factor Xa with neutral P1 moieties
Keywords: فاکتور Xa; Blood coagulation; Factor Xa; Thrombin, trypsin; Selectivity; BMS-740808; Aminobenzisoxazole; P-methoxyphenyl and 3-phenylcarboxamido P1; Dog ‘N-in-one’ pharmacokinetics; Oral bioavailability; Clearance; Vdss; Half-life; Rabbit AV Shunt efficacy